Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.

International Journal of Radiation Oncology, Biology, Physics
Louis ConstineNancy P Mendenhall

Abstract

Subsequent malignant neoplasms (SMNs) are a dominant cause of morbidity and mortality in children treated for Hodgkin's disease (HD). We evaluated select demographic and therapeutic factors associated with SMNs, specifically gender and radiation dose. A total of 930 children treated for HD at five institutions between 1960 and 1990 were studied. Mean age at diagnosis was 13.6 years, and mean follow-up was 16.8 years (maximum, 39.4 years). Treatment included radiation alone (43%), chemotherapy alone (9%), or both (48%). We found that SMNs occurred in 102 (11%) patients, with a 25-year actuarial rate of 19%. With 15,154 patient years of follow-up, only 7.18 cancers were expected (standardized incidence ratio [SIR] = 14.2; absolute excess risk [AER] = 63 cases/10,000 years). The SIR for female subjects, 19.93, was significantly greater than for males, 8.41 (p < 0.0001). After excluding breast cancer, the SIR for female patients was 15.4, still significantly greater than for male patients (p = 0.0012). Increasing radiation dose was associated with an increasing SIR (p = 0.0085). On univariate analysis, an increased risk was associated with female gender, increasing radiation dose, and age at treatment (12-16 years). Using logistic ...Continue Reading

Associated Clinical Trials

References

May 1, 1976·Cancer·S S DonaldsonH S Kaplan
May 15, 1987·International Journal of Cancer. Journal International Du Cancer·J M KaldorF E Neal
Apr 20, 2001·Journal of the National Cancer Institute·J P NegliaL L Robison
Nov 7, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Foss AbrahamsenS Kvaløy
Apr 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas JostingUNKNOWN German Hodgkin's Lymphoma Study Group
Jul 24, 2003·JAMA : the Journal of the American Medical Association·Lois B TravisEthel Gilbert
Oct 6, 2005·Journal of the National Cancer Institute·Lois B TravisMitchell H Gail
Jan 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mylène BassalNina S Kadan-Lottick
Dec 5, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M C Cardous-UbbinkF E van Leeuwen

❮ Previous
Next ❯

Citations

May 23, 2009·Breast Cancer Research and Treatment·Sonia K A Nguyen, Anne Dagnault
Mar 14, 2009·Thyroid : Official Journal of the American Thyroid Association·Anna M SawkaDavid P Goldstein
Mar 12, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P M BarbaroD S Ziegler
Jul 17, 2010·Journal of the National Cancer Institute·Debra L FriedmanJoseph P Neglia
Aug 26, 2010·Journal of Pediatric Hematology/oncology·Ebru Yilmaz KeskinUlker Kocak
Jun 27, 2009·The Cancer Journal·Smita Bhatia, Louis S Constine
May 30, 2012·BMC Cancer·Ezzeldin M IbrahimMeteb Al-Foheidi
Jul 14, 2011·Journal of Clinical Research in Pediatric Endocrinology·Metin DemirkayaOkan Akacı
Mar 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K C HorstR T Hoppe
Oct 11, 2014·Journal of the National Cancer Institute·Arnold L PotoskyUNKNOWN AYA HOPE Study Collaborative Group
May 6, 2009·In Vivo·Joel S Greenberger
Apr 6, 2013·European Journal of Pediatrics·Chrissa Sioka
May 28, 2016·Endocrine-related Cancer·Mark WijnenSebastian Neggers
Apr 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chaya S MoskowitzKevin C Oeffinger
Oct 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Debra L FriedmanCindy L Schwartz
May 18, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Burton E AppelCindy L Schwartz
Jun 24, 2015·Journal of Applied Clinical Medical Physics·Michael D Mills, Robert J Schulz
Feb 17, 2015·BJU International·Nikesh ThiruchelvamKarl-Dietrich Sievert
Sep 3, 2017·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Yael E Derman
Mar 22, 2012·Environmental and Molecular Mutagenesis·C SalasS Frias
Jun 20, 2014·International Journal of Cancer. Journal International Du Cancer·Daniel K ChoiNobuko Hijiya
Sep 8, 2020·Asia-Pacific Journal of Clinical Oncology·Eva KooAnita R Skandarajah
Mar 2, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Tamara Abou-AntounAline Saad
Feb 18, 2010·Journal of Applied Clinical Medical Physics·Maria T Vlachaki, Sanath Kumar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
Mohamed A Alm El-DinAlphonse G Taghian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Marie L De BruinFlora E van Leeuwen
JAMA : the Journal of the American Medical Association
Lois B TravisEthel S Gilbert
© 2022 Meta ULC. All rights reserved